000989.SZ
九芝堂
SZSE · Healthcare · C 制造业 · CN
CNY 8.66
−4.20%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.4B | 2.2B | 2.4B | 3.0B | 3.0B |
| Cost of Revenue | 954.8M | 893.2M | 969.5M | 1.2B | 1.3B |
| Gross Profit | 1.4B | 1.3B | 1.4B | 1.8B | 1.8B |
| Operating Expenses | |||||
| R&D Expense | 144.4M | 144.0M | 146.2M | 145.3M | 142.4M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 228.9M | 217.2M | 220.8M | 209.8M | 241.9M |
| Selling & Marketing Expense | 693.6M | 691.1M | 829.9M | 1.1B | 1.1B |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 1.1B | 1.1B | 1.2B | 1.5B | 1.5B |
| Cost and Expenses | 2.1B | 2.0B | 2.2B | 2.7B | 2.8B |
| Operating Income (EBIT) | 397.6M | 307.4M | 251.3M | 349.8M | 454.1M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 397.4M | 307.5M | 252.7M | 350.6M | 454.7M |
| Income Tax Expense | 59.0M | 47.9M | 37.5M | 54.8M | 100.1M |
| Bottom Line | |||||
| Net Income | 271.0M | 222.6M | 216.2M | 297.4M | 358.0M |
| Earnings from Cont. Ops | 338.4M | 259.6M | 215.2M | 295.8M | 354.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 271.0M | 222.6M | 216.2M | 297.4M | 358.0M |
| Per Share | |||||
| Basic EPS | CN¥0.32 | CN¥0.26 | CN¥0.25 | CN¥0.35 | CN¥0.42 |
| Diluted EPS | CN¥0.32 | CN¥0.26 | CN¥0.25 | CN¥0.35 | CN¥0.42 |
| Revenue Per Share | CN¥2.83 | CN¥2.63 | CN¥2.79 | CN¥3.46 | CN¥3.54 |
| Shares | |||||
| Basic Shares Outstanding | 846.3M | 846.4M | 850.2M | 855.9M | 856.0M |
| Diluted Shares Outstanding | 846.3M | 846.4M | 850.2M | 855.9M | 856.0M |
| Profitability Metrics | |||||
| EBITDA | — | 429.0M | 367.5M | 471.3M | 589.6M |
| D&A | — | 121.6M | 116.1M | 121.5M | 135.5M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026